BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 675925)

  • 1. Urinary cytology and bladder biopsy in patients with bladder cancer.
    Loening S; Fallon B; Narayana A; Penick GD; Hawtrey C; Culp DA; Bonney WW
    Urology; 1978 Jun; 11(6):591-5. PubMed ID: 675925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing treatment response after induction Bacillus Calmette-Guerin for carcinoma in situ of the urinary bladder: can post-induction random bladder biopsies be avoided?
    Smith PJ; Lotan Y; Raj GV; Sagalowsky AI; Margulis V
    Cytopathology; 2014 Apr; 25(2):108-11. PubMed ID: 23551700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal study of bladder cancer with cytology and biopsy.
    Loening S; Narayana A; Yoder L; Slymen D; Weinstein S; Penick G; Culp D
    Br J Urol; 1978 Dec; 50(7):496-501. PubMed ID: 572723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors influencing the recurrence rate of bladder cancer.
    Loening S; Narayana A; Yoder L; Slymen D; Weinstein S; Penick G; Culp D
    J Urol; 1980 Jan; 123(1):29-31. PubMed ID: 7351716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of NMP22 BladderChek test and urine cytology for the detection of recurrent bladder cancer.
    Kumar A; Kumar R; Gupta NP
    Jpn J Clin Oncol; 2006 Mar; 36(3):172-5. PubMed ID: 16520358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of voided urine and bladder barbotage cytology in detecting transitional cell carcinoma of the urinary tract.
    Konety BR; Metro MJ; Melham MF; Salup RR
    Urol Int; 1999; 62(1):26-30. PubMed ID: 10436427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of bladder washings and urine cytology in the diagnosis of bladder cancer and its correlation with selected biopsies of the bladder mucosa.
    Zein T; Wajsman Z; Englander LS; Gamarra M; Lopez C; Huben RP; Pontes JE
    J Urol; 1984 Oct; 132(4):670-1. PubMed ID: 6471209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surveillance of patients with bladder carcinoma using fluorescent in-situ hybridization on bladder washings.
    Bergman J; Reznichek RC; Rajfer J
    BJU Int; 2008 Jan; 101(1):26-9. PubMed ID: 17850364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of routine transurethral biopsy and isolated upper tract cytology after intravesical treatment of high-grade non-muscle invasive bladder cancer.
    Lightfoot AJ; Rosevear HM; Nepple KG; O'Donnell MA
    Int J Urol; 2012 Nov; 19(11):988-93. PubMed ID: 22762480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical application of NMP22 in the management of transitional cell carcinoma of the bladder.
    Sawczuk IS; Bagiella E; Sawczuk AT; Yun EJ
    Cancer Detect Prev; 2000; 24(4):364-8. PubMed ID: 11059567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bladder biopsy of normal-appearing mucosa is not helpful in patients with unexplained positive cytology after nonmuscle invasive bladder cancer.
    Musser JE; O'Shaughnessy MJ; Kim PH; Herr HW
    J Urol; 2015 Jan; 193(1):48-52. PubMed ID: 24960468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Significance of random biopsies of healthy mucosa in superficial bladder tumor].
    Fernández Gómez JM; Rodríguez Martínez JJ; Escaf Barmadah S; Pérez García J; García J; Casasola Chamorro J
    Arch Esp Urol; 2000 Nov; 53(9):785-97. PubMed ID: 11196385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follow-up in non-muscle-invasive bladder cancer-International Bladder Cancer Network recommendations.
    Kassouf W; Traboulsi SL; Schmitz-Dräger B; Palou J; Witjes JA; van Rhijn BW; Grossman HB; Kiemeney LA; Goebell PJ; Kamat AM
    Urol Oncol; 2016 Oct; 34(10):460-8. PubMed ID: 27368880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discrepancies between cytology, cystoscopy and biopsy in bladder cancer detection after Bacille Calmette-Guerin intravesical therapy.
    Hara T; Takahashi M; Gondo T; Nagao K; Ohmi C; Sakano S; Naito K; Matsuyama H
    Int J Urol; 2009 Feb; 16(2):192-5. PubMed ID: 19054166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The diagnostic value of urine versus bladder washing in patients with bladder cancer.
    Murphy WM; Crabtree WN; Jukkola AF; Soloway MS
    J Urol; 1981 Sep; 126(3):320-2. PubMed ID: 7277589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of transurethral bladder biopsy after intravesical bacillus Calmette-Guérin instillation therapy for nonmuscle invasive bladder cancer: a retrospective, single center study and cumulative analysis of the literature.
    Swietek N; Waldert M; Rom M; Schatzl G; Wiener HG; Susani M; Klatte T
    J Urol; 2012 Sep; 188(3):748-53. PubMed ID: 22819422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
    Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A
    J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic contribution of bladder washing and multiple biopsies in bladder cancers.
    Denis L; Nowé P; Declercq G
    Eur Urol; 1980; 6(3):137-8. PubMed ID: 7371657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Alternatives to the cystoscopic control of bladder neoplasms].
    Páez Borda A; Luján Galán M; Martín Osés E; Berenguer Sánchez A
    Arch Esp Urol; 1997 Dec; 50(10):1079-83. PubMed ID: 9494196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematuria screening test for urinary bladder mucosal infiltration in cervical cancer.
    Chuttiangtum A; Udomthavornsuk B; Chumworathayi B
    Asian Pac J Cancer Prev; 2012; 13(10):4931-3. PubMed ID: 23244084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.